TABLE 3

Relative distribution of metabolites in pooled urine, feces, and bile after oral administration of [14C]GDC-0449 to rats and dogs

The percentage of the dose was calculated as the percentage of the sample multiplied by the percentage of excretion from n = 2 for dogs and n = 3 for rats.

AnalytePercentage of Dose in RatsPercentage of Dose in Dogs
Urine (0–24 h)Feces (0–48 h)Bile (0–24 h)Urine (0–192 h)Feces (0–144 h)Bile (0–240 h): M
MFMeanMFMeanMFMeanMFMeanMFMean
GDC-0449DDD44.740.242.50.30.50.40.40.20.32313.218.13.8
M1DDDDDDDDDa3.25.64.4
M30.40.10.315.910.213.16.65.66.10.30.30.318.92823.51.3
M40.2D0.22.50.51.50.30.70.52.4
M5D0.30.35.68.97.30.20.50.43.8
M6DDDD
M70.30.40.4
M80.20.20.2
M90.31.10.71.75.73.7DbDbD
M100.40.30.40.20.30.3
M11DDDDDD0.80.60.7
M120.30.70.5
M13DDDDDDDDD0.30.20.37.112.19.63.1
M140.5D0.50.40.80.60.80.90.90.61.20.91.6
M153.14.33.70.7
M161.6
M17DDD12.77.0b9.9
M18DDDDDDDDDDDD3.35.64.51.0
Total dose identifiedc1.71.81.862.756.959.829.724.527.12.64.13.458.668.863.719.3
Total dose pooledd2.22.32.388.090.790.738.135.336.73.55.74.662.979.971.421.2
  • M, male; F, female; D, detected by LC-MS/MS and radiochromatographic peak was not discernible.

  • a —, not detected.

  • b This metabolite coeluted with M9.

  • c These figures represent the total percentage of the dose of the listed metabolites; the remainder of the radioactivity was distributed in various minor peaks (each representing <5% of the dose) throughout the radiochromatogram. These minimal peaks were not characterized.

  • d These data represent the total percentage of the dose excreted in each route over the time period of sample pooled.